<?xml version="1.0" encoding="iso-8859-1"?>
<legaldoc>
    <law type="statute"><section><amendatorysection amended="yes" chaptername="HEALTH OCCUPATIONS AND PROFESSIONS" statutenumber="38-28,110"><bookinfo>Revised Statutes Annual Supplement, 2015</bookinfo><statuteno>38-28,110</statuteno><catchline>Drug product selection; terms, defined.</catchline><para>For purposes of the Nebraska Drug Product Selection Act, unless the context otherwise requires:</para><para>(1) Bioequivalent means drug products: (a) That are legally marketed under regulations promulgated by the federal Food and Drug Administration; (b) that are the same dosage form of the identical active ingredients in the identical amounts as the drug product prescribed; (c) that comply with compendial standards and are consistent from lot to lot with respect to (i) purity of ingredients, (ii) weight variation, (iii) uniformity of content, and (iv) stability; and (d) for which the federal Food and Drug Administration has established bioequivalent standards or has determined that no bioequivalence problems exist;</para><para>(2) Brand name means the proprietary or trade name selected by the manufacturer, distributor, or packager for a drug product and placed upon the labeling of such product at the time of packaging;</para><para>(3) Chemically equivalent means drug products that contain amounts of the identical therapeutically active ingredients in the identical strength, quantity, and dosage form and that meet present compendial standards;</para><para>(4) Drug product means any drug or device as defined in section 38-2841;</para><para>(5) Drug product select means to dispense, without the practitioner's express authorization, an equivalent drug product in place of the brand-name drug product contained in a medical order of such practitioner;</para><para>(6) Equivalent means drug products that are both chemically equivalent and bioequivalent; and</para><para>(7) Generic name means the official title of a drug or drug combination as determined by the United States Adopted Names Council and accepted by the federal Food and Drug Administration of those drug products having the same active chemical ingredients in the same strength and quantity.</para></amendatorysection></section><source><para>Laws 1977, LB 103, &#167; 2; </para><para>Laws 1983, LB 476, &#167; 21; </para><para>Laws 1989, LB 342, &#167; 36; </para><para>Laws 1996, LB 1044, &#167; 720; </para><para>Laws 1998, LB 1073, &#167; 148; </para><para>Laws 2001, LB 398, &#167; 76; </para><para>Laws 2003, LB 667, &#167; 15; </para><para>Laws 2005, LB 382, &#167; 11; </para><para>Laws 2007, LB296, &#167; 622; </para><para>Laws 2007, LB463, &#167; 1232; </para><para>R.S.1943, (2009), &#167; 71-5402; </para><para>Laws 2015, LB37, &#167; 61. </para><effectivedate>August 30, 2015</effectivedate></source></law>
</legaldoc>